Compare CMT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMT | DERM |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | 1239 | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.8M | 190.3M |
| IPO Year | 1996 | 2021 |
| Metric | CMT | DERM |
|---|---|---|
| Price | $23.89 | $7.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $24.00 | $12.67 |
| AVG Volume (30 Days) | 19.5K | ★ 204.4K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.72 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $284,290,000.00 | $61,858,000.00 |
| Revenue This Year | $4.58 | $39.72 |
| Revenue Next Year | $6.04 | $63.24 |
| P/E Ratio | $89.48 | ★ N/A |
| Revenue Growth | 5.49 | ★ 10.20 |
| 52 Week Low | $16.60 | $4.31 |
| 52 Week High | $28.69 | $9.56 |
| Indicator | CMT | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 67.03 |
| Support Level | $22.80 | $7.25 |
| Resistance Level | $25.38 | $8.29 |
| Average True Range (ATR) | 1.10 | 0.39 |
| MACD | -0.22 | 0.06 |
| Stochastic Oscillator | 26.38 | 87.61 |
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.